All Stories

  1. High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL

    Article • SLAS DISCOVERY, May 2018, SAGE Publications

    Dr Ksenia Matlawska-Wasowska

  2. Drugging DNA repair to target T-ALL cells

    Article • Leukemia & Lymphoma, November 2017, Taylor & Francis

    Dr Ksenia Matlawska-Wasowska

  3. Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia

    Article • Pediatric Blood & Cancer, April 2017, Wiley

    Dr Ksenia Matlawska-Wasowska

  4. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia

    Article • Science Signaling, November 2016, American Association for the Advancement of Science

    Dr Ksenia Matlawska-Wasowska

  5. Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia

    Article • Pediatric Blood & Cancer, November 2016, Wiley

    Dr Ksenia Matlawska-Wasowska

  6. CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS

    Article • Leukemia, October 2016, Springer Science + Business Media

    Dr Ksenia Matlawska-Wasowska

  7. ­­­­Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia

    Article • Oncotarget, April 2016, Impact Journals, LLC

    Dr Ksenia Matlawska-Wasowska

  8. Pyrosequencing for Classification of Human FcγRIIIA Allotypes: A Comparison with PCR-Based Techniques

    Article • Molecular Diagnosis & Therapy, September 2014, Springer Science + Business Media

    Dr Ksenia Matlawska-Wasowska

  9. The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro

    Article • Toxicology in Vitro, March 2014, Elsevier

    Dr Ksenia Matlawska-Wasowska

  10. Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies

    Article • Leukemia, January 2013, Nature

    Dr Ksenia Matlawska-Wasowska

  11. GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia

    Article • Leukemia, April 2011, Nature

    Dr Ksenia Matlawska-Wasowska

  12. Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells

    Article • Chemico-Biological Interactions, October 2010, Elsevier

    Dr Ksenia Matlawska-Wasowska

  13. The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis

    Article • BMC Microbiology, January 2010, Springer Science + Business Media

    Dr Ksenia Matlawska-Wasowska

  14. Identification of Components of the Sigma B Regulon in Listeria monocytogenes That Contribute to Acid and Salt Tolerance

    Article • Applied and Environmental Microbiology, September 2008, ASM Journals

    Dr Ksenia Matlawska-Wasowska, Martin Wiedmann Wiedmann

  15. Trans geometry in platinum antitumor complexes

    Article • Coordination Chemistry Reviews, July 2008, Elsevier

    Dr Ksenia Matlawska-Wasowska

  16. Analysis of aclarubicin-induced cell death in human fibroblasts

    Article • Cell Biology International, September 2007, Wiley

    Dr Ksenia Matlawska-Wasowska

  17. Genotoxicity of novel trans-platinum(II) complex with diethyl (pyridin-4-ylmethyl)phosphate in human non-small cell lung cancer cells A549

    Article • Chemico-Biological Interactions, June 2007, Elsevier

    Dr Ksenia Matlawska-Wasowska

  18. Novel Analogues of 5-Fluorouracil - Synthesis, X-ray Crystallography, and Cytotoxic Effects in Normal Human Peripheral Blood Lymphocytes and Colon Adenocarcinoma HT 29

    Article • European Journal of Inorganic Chemistry, August 2005, Wiley

    Dr Ksenia Matlawska-Wasowska